20254 ⎘
Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
#302Methods and pharmaceutical compositions for decorporation of radioactive compounds
#303Copper antagonist compositions
#304Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
#305Spray-Drying process for producing a dry caritine powder or granulate
#306Use of acetyl L-carnitine for the preparation of a medication for the preventive therapy for pain
#307Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
#308Pharmaceutical Combination for the Treatment of Luts
#309COMPOSITIONS AND METHODS OF TREATING CHRONIC KIDNEY DISEASE
#310Resuscitation fluid
#311Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
#312Carnitines for treating or preventing disorders caused by andropause
#313Use of the acetyl L-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus
#314Pharmaceutical composition for gout
#315“Micro-patch” for assessment of the local microvasculature and microcirculatory vasoreactivity
#316Micronutrient formulations for pulmonary and heart health
#317Medicament for preventing and/or treating peripheral neuropathies
#318Powder inhaler featuring reduced compaction inhaler
#319Method for the Management of Incontinence
#320Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for opthalmic use in the form of eye drops
#321Composition and method of retarding viral activity and reducing viral replication
#322Use of L-carnitine for the treatment of cardiovascular diseases
#323CREATINE ESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS
#324Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
#325NOVEL COMPOSITION AND METHOD FOR THE TREATMENT OF HYPERTENSION
#326Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#327Treating pulmonary disorders with gaseous agent causing repletion of GSNO
#328Medicament for preventing and/or treating peripheral neuropathies
#329Rate control during AF using cellular intervention to modulate AV node
#330Treatment of multiple sclerosis with brain targeted anti oxidant compounds
#331Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
#332Food and beverages containing L-carnitine derivatives
#333Novel chemical entities and methods for their use in treatment of metabolic disorders
#334Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
#335Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
#336Pasting agent
#337Use of an alkanoyl L-carnitine for the preparation of a medication to treat anhedonia
#338Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
#339Methods of treating microbial infections in humans and animals
#340Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
#341Fucoidan-containing cosmetics
#342Compounds, compositions and methods for treating neuropsychiatric disorders
#343Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
#344Labeled creatine ethyl ester hydrochloride
#345Methods and compositions for promoting axon regeneration and cell replacement therapy
#346Reagents and method for spatio-temporal control of gene expression by illumination
#347Administration of isovaleryl L-carnitine to stimulate osteoblastic activity
#348Eye nutritional supplement
#349Materials and methods for the treatment of depression
#350Use of L-carnitine in the prevention and treatment of hearing loss
#351Methods and compositions for the diagnosis of asthma
#352Nutritional composition and method of inhibiting smooth muscle cell contraction thereof
#353Amino acid compositions
#354Amino acid compositions
#355Amino acid compositions
#356Method for increasing muscle strength
#357Amino acid compositions
#358Amino acid compositions